Limitation of Complement Activation by Perfluorocarbon Emulsions: Superiority of Lecithin-Emulsified Preparations

References

• Craddock P. R., Fehr J., Dalmasso A. P., Brigham K. L., Jacob H. S. Hemodialysis neutropenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest. 1977; 59: 879–888
   PubMed Web of Science ®Google Scholar
• Craddock P. R., Fehr J., Brigham K. L., Kronenberg R. S., Jacob H. S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N. Engl. J. Med. 1977; 296: 769–774
   PubMed Web of Science ®Google Scholar
• Craddock P. R., Hammerschmidt D. E., White J. G., Dalmasso A. P., Jacob H. S. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism of complement-mediated leukostasis and leukopenia. J. Clin. Invest. 1977; 60: 261–264
   Web of Science ®Google Scholar
• Hammerschmidt D. E., Bowers T. K., Lammi-Keefe C. J., Jacob H. S., Craddock P. R. Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation. Blood 1980; 55: 898–902
   PubMed Web of Science ®Google Scholar
• Ivanovich P., Chenoweth D. E., Schmidt R., Klinkmann H., Boxer L. A., Jacob H. S., Hammerschmidt D. E. Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Intern. 1983; 24: 758–763
   PubMed Web of Science ®Google Scholar
• Stroncek D., Craddock P. R., Hammerschmidt D. E. Effect of dialyzer re-use on complement activation and leukopenia in hemodialysis. J. Lab. Clin. Med. 1984; 104: 304–311
   PubMed Web of Science ®Google Scholar
• Hammerschmidt D. E., Stroncek D. F., Bowers T. K., Lammi-Keefe C. J., Ozolins A., Kurth D. M., Nicoloff D. M., Lillehei R. C., Jacob H. S., Craddock P. R. Complement activation and neutropenia occurring during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1981; 81: 370–377
   PubMed Web of Science ®Google Scholar
• Hugli T. E., Chenoweth D. E. Biologically active peptides of complement: techniques and significance of C3a and C5a measurements. Immunoassays: Clinical Laboratory Techniques for the 1980s, R. M. Nakamura, W. R. Dito, E. S. Tucker, III. Alan R. Liss, Inc., New York 1980; 443–460
   Google Scholar
• Hammerschmidt D. E. Clinical utility of complement anaphylatoxin assays. Complement 1986; 3: 166–176
   PubMedGoogle Scholar
• Chenoweth D. E. Biocompatibility of hemodialysis membranes: evaluation with C3a anaphylatoxin radioimmunoassays. ASAIO J. 1984; 7: 44–49
   Google Scholar
• Chenoweth D. E., Cheung A. K., Henderson L. W. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Intern. 1983; 24: 764–769
   PubMed Web of Science ®Google Scholar
• Hakim R. M., Breillatt J., Lazarus J. M., Port F. K. Complement activation and hypersensitivity reactions to dialysis membranes. N. Engl. J. Med. 1984; 311: 878–882
   PubMed Web of Science ®Google Scholar
• Ohyanagi H., Toshima K., Sekita M., Okamoto M., Itoh T., Mitsuno T. Clinical studies of perfluorochemical whole blood substitutes: safety of Fluosol-DA (20%) in normal human volunteers. Clin. Ther. 1979; 2: 306–312
   Web of Science ®Google Scholar
• Honda K., Hoshino S., Shoji M. Clinical use of a blood substitute. N. Engl. J. Med. 1980; 303: 391–392
   PubMed Web of Science ®Google Scholar
• Mitsuno T., Harumasa O., Naito R. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA). Ann. Surg. 1982; 195: 60–69
   PubMed Web of Science ®Google Scholar
• Vercellotti G. M., Hammerschmidt D. E., Craddock P. R., Jacob H. S. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse reactions in treated patients and rationale for corticosteroid prophylaxis. Blood 1982; 59: 1299–1304
   PubMed Web of Science ®Google Scholar
• O'Flaherty J. T., Craddock P. R., Jacob H. S. Mechanism of anticomplementary activity of corticosteroids in vivo: possible relevance to endotoxin shock. Proc. Soc. Exp. Biol. Med. 1977; 154: 206–209
   PubMed Web of Science ®Google Scholar
• Hammerschmidt D. E., White J. G., Craddock P. R., Jacob H. S. Corticosteroids inhibit complement-mediated granulocyte aggregation: a possible mechanism for their efficacy in shock states. J. Clin. Invest. 1979; 63: 798–803
   PubMed Web of Science ®Google Scholar
• Hammerschmidt D. E., Harris P. D., Wayland J. H., Craddock P. R., Jacob H. S. Complement-induced granulocyte aggregation. in vivo. Am. J. Pathol. 1981; 102: 146–150
   PubMed Web of Science ®Google Scholar
• Tremper K. K., Friedman A. E., Levine E. M., Lapin R., Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen transport fluid, Fluosol-DA. N. Engl. J. Med. 1982; 307: 277–283
   PubMed Web of Science ®Google Scholar
• Police A. M., Waxman K., Tominaga G. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss. Crit. Care Med. 1985; 13: 96–98
   PubMed Web of Science ®Google Scholar
• Karn K. E., Ogburn P. L., Julian T., Cerra F. B., Hammerschmidt D. E., Vercellotti G. M. Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage. Obstet. Gynecol. 1985; 65: 127–130
   PubMed Web of Science ®Google Scholar
• Dyerberg J., Bang H. O. Lipid metabolism, atherogenesis and hæmostasis in Eskimos: the role of the prostaglandin-3 family. Hæmostasis 1979; 8: 227–233
   PubMedGoogle Scholar
• Hammerschmidt D. E., Ogburn P. L., Williams J. E. Amniotic fluid activates complement: a role in amniotic fluid embolism syndrome. J. Lab. Clin. Med. 1984; 104: 901–907
   PubMed Web of Science ®Google Scholar
• Gewurz H., Mold C., Siegel J., Fiedel B. C-reactive protein and the acute phase response. Adv. Intern. Med. 1982; 27: 345–372
   PubMedGoogle Scholar
• Virmani R., Warren D., Rees R., Fink L. M., English D. Effects of perfluorochemical on phagocytic function of leukocytes. Transfusion 1983; 23: 512–515
   PubMed Web of Science ®Google Scholar
• Hammerschmidt D. E., Weaver L. J., Hudson L. D., Craddock P. R., Jacob H. S. Association of complement activation and elevation of plasma-C5a with adult respiratory distress syndrome: pathophysiologic relevance and possible prognostic value. Lancet 1980; 1: 947–949
   PubMed Web of Science ®Google Scholar
• Hammerschmidt D. E. Statistical spreadsheets for data analysis in the biomedical sciences. Hematology Publications of the University of Minnesota (Minneapolis) 1985
   Google Scholar
• Armitage P. (Section 7.1) One-way analysis of variance. Statistical Methods in Medical Research, P. Armitage. Blackwell Scientific Publications, Oxford 1971; 189–216
   Google Scholar